Perspectives on the etiology of chronic rhinosinusitis: an immune barrier hypothesis.

American journal of rhinology Pub Date : 2008-11-01 Epub Date: 2008-09-10 DOI:10.2500/ajr.2008.22.3228
Robert C Kern, David B Conley, William Walsh, Rakesh Chandra, Atsushi Kato, Anju Tripathi-Peters, Leslie C Grammer, Robert P Schleimer
{"title":"Perspectives on the etiology of chronic rhinosinusitis: an immune barrier hypothesis.","authors":"Robert C Kern, David B Conley, William Walsh, Rakesh Chandra, Atsushi Kato, Anju Tripathi-Peters, Leslie C Grammer, Robert P Schleimer","doi":"10.2500/ajr.2008.22.3228","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Chronic rhinosinusitis (CRS) has been defined as persistent symptomatic inflammation of the nasal and sinus mucosa resulting from the interaction of multiple host and environmental factors. Recent studies have implicated Alternaria fungi or toxigenic Staphylococcus aureus as critical agents in CRS pathogenesis. The emphasis on environmental agents in CRS etiology has focused interest toward elimination of those agents as the prime mechanism of therapy. This viewpoint is in marked contrast to the current perspective on some other chronic inflammatory epithelial disorders that afflict the skin, lungs, and gut, wherein host factors are believed to predispose to disease expression in the presence of ubiquitous environmental agents.</p><p><strong>Methods: </strong>The current review evaluates CRS etiology from this perspective and considers that CRS develops, in part, as an outcome of a dysfunctional host response. Specifically, evidence from our laboratory and others will be reviewed indicating that CRS is associated with a failure of the mechanical and immunologic barriers across the nasal mucosa. The hypothesis would further propose that genetic and epigenetic variation predisposes susceptible individuals to barrier failure in the presence of environmental stress leading to CRS.</p><p><strong>Results: </strong>From this unifying perspective, bacteria and fungi are seen as disease modifiers rather than primary etiologic agents.</p><p><strong>Conclusion: </strong>The goal is to place concepts of CRS pathophysiology in a framework consistent with a current understanding of chronic inflammation in general and epithelial disease in particular.</p>","PeriodicalId":72175,"journal":{"name":"American journal of rhinology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2008-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2802263/pdf/nihms-164928.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of rhinology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2500/ajr.2008.22.3228","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2008/9/10 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Chronic rhinosinusitis (CRS) has been defined as persistent symptomatic inflammation of the nasal and sinus mucosa resulting from the interaction of multiple host and environmental factors. Recent studies have implicated Alternaria fungi or toxigenic Staphylococcus aureus as critical agents in CRS pathogenesis. The emphasis on environmental agents in CRS etiology has focused interest toward elimination of those agents as the prime mechanism of therapy. This viewpoint is in marked contrast to the current perspective on some other chronic inflammatory epithelial disorders that afflict the skin, lungs, and gut, wherein host factors are believed to predispose to disease expression in the presence of ubiquitous environmental agents.

Methods: The current review evaluates CRS etiology from this perspective and considers that CRS develops, in part, as an outcome of a dysfunctional host response. Specifically, evidence from our laboratory and others will be reviewed indicating that CRS is associated with a failure of the mechanical and immunologic barriers across the nasal mucosa. The hypothesis would further propose that genetic and epigenetic variation predisposes susceptible individuals to barrier failure in the presence of environmental stress leading to CRS.

Results: From this unifying perspective, bacteria and fungi are seen as disease modifiers rather than primary etiologic agents.

Conclusion: The goal is to place concepts of CRS pathophysiology in a framework consistent with a current understanding of chronic inflammation in general and epithelial disease in particular.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
慢性鼻炎病因透视:免疫屏障假说。
背景:慢性鼻窦炎(CRS)被定义为多种宿主和环境因素相互作用导致的鼻腔和鼻窦粘膜的持续性症状性炎症。最近的研究表明,交替真菌或毒性金黄色葡萄球菌是 CRS 发病的关键因素。强调环境因素在 CRS 病因中的作用,使人们把消除这些因素作为治疗的主要机制。这种观点与目前对其他一些困扰皮肤、肺部和肠道的慢性炎症性上皮性疾病的观点形成了鲜明对比,后者认为宿主因素在无处不在的环境因子作用下容易导致疾病的发生:本综述从这一角度评估了 CRS 的病因,并认为 CRS 的发生部分是宿主反应失调的结果。具体来说,我们将回顾本实验室和其他实验室的证据,这些证据表明 CRS 与鼻粘膜机械和免疫屏障失效有关。该假说进一步提出,遗传和表观遗传变异使易感个体在环境压力下容易出现屏障失效,从而导致 CRS:从这一统一的视角来看,细菌和真菌被视为疾病的改变因素,而非主要病原体:结论:我们的目标是将 CRS 病理生理学概念置于一个框架中,使其与当前对慢性炎症尤其是上皮疾病的理解相一致。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Perspectives on the etiology of chronic rhinosinusitis: an immune barrier hypothesis. Comparison of laryngeal mask with endotracheal tube for anesthesia in endoscopic sinus surgery. The effect of nasal surgery on snoring. Results of endoscopic maxillary mega-antrostomy in recalcitrant maxillary sinusitis. The efficacy of topical antibiofilm agents in a sheep model of rhinosinusitis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1